RALIEGH, N.C., June 1, 2016 /PRNewswire/ -- Myocardial Solutions, Inc. (“MSI”) announced the completion of a $4 million Series A raise for the commercialization of its cardiac diagnostic software application for post processing of Magnetic Resonance Imaging (“MRI”). The Company’s proprietary SENC software improves the speed and ease of existing Cardiac MRI (“CMR”) testing. The software has the ability to reduce patient time within the magnet to less than 5 minutes versus 20-60 minutes historically. With single heart beat image acquisition, the SENC technology addresses the technical complexity, long procedure times and patient anxiety associated with traditional CMR. Additionally, MSI’s fast processing and algorithm quantifies images for objective results and without the need for contrast media, breath hold or radiation. The goal is to expand the use of CMR, the gold standard for strain imaging resolution and accuracy, in clinical settings.
The technology was developed by Dr. Nael Osman, a radiology professor at Johns Hopkins Medical Center and a founder of Myocardial Solutions, Inc. The fast SENC processing and analysis software creates the opportunity to commercialize the technology. “I am excited to finally have the resources to bring this novel technology to market. The clinical applications for the SENC technology has been proven and validated through our research efforts.” said Dr. Osman. The technology has been long used in major research centers and is the recognized gold standard for heart wall motion (strain) analysis. Over 70 research centers have produced more than 250 peer-reviewed articles on the technology with over 50 articles appearing in Circulation or JACC, the highest standard for cardiac literature review.
Dr. Osman has teamed with John Funkhouser, President of MSI, to transform cardiac diagnostic imaging by developing simple, fast and accurate tests for widespread clinical adoption. “The rapid quantitative analysis of changes in heart wall motion may open new opportunities to evaluate heart function in asymptomatic patients as a potential preventive measure for heart failure.”
About Myocardial Solutions, Inc.:
The Company was founded in January, 2016 to commercialize software applications for fast processing of CMR imaging with objective quantified results. The goal is to create wide spread adoption of CMR diagnostics.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/myocardial-solutions-inc-completes-initial-financing-300277266.html
SOURCE Myocardial Solutions, Inc.
